Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy (STARMEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01955187
Recruitment Status : Completed
First Posted : October 7, 2013
Last Update Posted : January 18, 2020
Sponsor:
Collaborators:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Hospital Universitario Fundación Alcorcón
Fundación para la Investigación Biomédica Hospital Universitario 12 de Octubre
Biobanco REDinREN
ERA-EDTA
REDinREN
Spanish Society of Nephrology
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
University Hospital, Aachen
Information provided by (Responsible Party):
Manel Praga, MD, Hospital Universitario 12 de Octubre

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 26, 2019
Actual Study Completion Date : June 26, 2019